Novo

The next generation of blockbuster obesity drugs isn't trying to replace GLP-1 medicines.Instead, drugmakers are…
Read More...

The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersEvery time Novo urges investors to look ahead,…
Read More...

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
Read More...

Michael Siluk | UCG | Universal Images Group | Getty ImagesShares in Swedish microcap stock Nanexa more than doubled…
Read More...

Novo CEO Mike Doustdar told CNBC that the pharmaceutical giant is considering M&A opportunities as it faces…
Read More...

Novo shares fell as much as 7% on Monday after the company laid out new growth ambitions to revive its fortunes in…
Read More...

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen,…
Read More...

Novo Nordisk's quarterly beat and guidance increase did little to resolve Wall Street's biggest concern: whether the…
Read More...

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
Read More...

Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart drug trial failed to…
Read More...